LivaNova (LIVN) Receivables - Net (2015 - 2026)
LivaNova (LIVN) reported Receivables - Net of $229.3 million for Q1 2026, up 13.46% on a YoY basis from $202.1 million in Q1 2025, and up 6.15% sequentially from $216.0 million in Q4 2025.
LivaNova (LIVN) Receivables - Net (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Receivables - Net data on file, last reported at $229.3 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Net rose 13.46% year-over-year to $229.3 million; the trailing twelve-month figure through Mar 2026 stood at $229.3 million (up 13.46% YoY), and the FY2025 full-year result was $216.0 million, up 11.82% from the prior year.
- Receivables - Net improved to $229.3 million in Q1 2026, from $216.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $229.3 million in Q1 2026 to a low of $172.1 million in Q3 2022.
- A 5-year average of $197.8 million and a median of $197.2 million in 2024 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net increased 17.46% in 2023 and retreated 10.19% in 2024, its largest moves.
- Tracing LIVN's Receivables - Net over 5 years: stood at $183.1 million in 2022, then gained by 17.46% to $215.1 million in 2023, then declined by 10.19% to $193.2 million in 2024, then climbed by 11.82% to $216.0 million in 2025, then rose by 6.15% to $229.3 million in 2026.
- Business Quant data shows LIVN's Receivables - Net at $229.3 million in Q1 2026, $216.0 million in Q4 2025, and $211.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229.27 Mn |
| Mar 31, 2026 | 229.27 Mn |
| Dec 31, 2025 | 215.99 Mn |
| Dec 31, 2025 | 215.99 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Sep 30, 2025 | 211.58 Mn |
| Jun 30, 2025 | 220.20 Mn |
| Jun 30, 2025 | 220.20 Mn |
| Mar 31, 2025 | 202.08 Mn |
| Mar 31, 2025 | 202.08 Mn |
| Dec 31, 2024 | 193.16 Mn |
| Dec 31, 2024 | 193.16 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Sep 30, 2024 | 197.16 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Jun 30, 2024 | 200.89 Mn |
| Mar 31, 2024 | 209.43 Mn |
| Mar 31, 2024 | 209.43 Mn |
| Dec 31, 2023 | 215.07 Mn |
| Dec 31, 2023 | 215.07 Mn |